Overview

Pharmacokinetics Study for Probucol

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and pharmacokinetics of probucol by multiple oral administration in healthy male subjects.
Phase:
Phase 4
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.
Treatments:
Probucol